Literature DB >> 9677257

Patching together the genetics of Gorlin syndrome.

S J Bale1, R T Falk, G R Rogers.   

Abstract

BACKGROUND: Gorlin syndrome is an autosomal dominant disorder characterized by developmental defects and susceptibility to cancer, especially to basal cell carcinomas. The genetic basis of this disorder has recently been elucidated.
METHODS: In this article previous studies are reviewed in which loss of heterozygosity analysis of tumours and normal tissue pointed to a region on chromosome 9 as being involved in Gorlin syndrome. In this light, Knudson's two-hit model is discussed. The identification of the involvement of the patched gene in Gorlin syndrome is reviewed. New data on genotype-phenotype correlations in the syndrome are presented.
RESULTS: Loss-of-heterozygosity studies, together with standard family studies using linkage analysis, have proved useful in identifying the location of a gene with complex phenotypic expression.
CONCLUSION: The application of the two-hit model, as utilized in loss-of-heterozygosity studies, has been very useful in elucidating the genetic basis of Gorlin syndrome. There may be a correlation between certain aspects of the mutations in patched and the clinical presentation of the disorder in families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677257     DOI: 10.1177/120347549800300109

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  5 in total

1.  Childhood cancer and developmental biology a crucial partnership.

Authors:  Sara Federico; Rachel Brennan; Michael A Dyer
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

2.  Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.

Authors:  Xiuwei Tang; Arianna L Kim; David J Feith; Anthony E Pegg; Justin Russo; Hong Zhang; Michelle Aszterbaum; Levy Kopelovich; Ervin H Epstein; David R Bickers; Mohammad Athar
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

3.  Molecular subgroups of medulloblastoma: the current consensus.

Authors:  Michael D Taylor; Paul A Northcott; Andrey Korshunov; Marc Remke; Yoon-Jae Cho; Steven C Clifford; Charles G Eberhart; D Williams Parsons; Stefan Rutkowski; Amar Gajjar; David W Ellison; Peter Lichter; Richard J Gilbertson; Scott L Pomeroy; Marcel Kool; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-12-02       Impact factor: 17.088

Review 4.  Molecular Classification of Medulloblastoma.

Authors:  Noriyuki Kijima; Yonehiro Kanemura
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-26       Impact factor: 1.742

Review 5.  CAR T Cell Therapy for Pediatric Brain Tumors.

Authors:  John D Patterson; Jeffrey C Henson; Rebecca O Breese; Kevin J Bielamowicz; Analiz Rodriguez
Journal:  Front Oncol       Date:  2020-08-12       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.